Details for 2016819325
Up to date per 01.04.2026
Actions
Details for 2016819325
Granted/Registered
European Patent
26.09.2018 A
26.06.2019 B1
08.01.2016
US
201662276237 P
17.10.2016
US
201662408921 P
A61K 31/4985 20060101AFI20170803BHEP
Owner
NeRRe Therapeutics LimitedStevenage Bioscience Catalyst Office F25 Incubator Building Gunnels Wood Road Stevenage, Hertfordshire SG1 2FXGB
Representative
No representatives present
Inventor
TROWER, MikeC/O NeRRe Therapeutics Limited Stevenage Bioscience Catalyst Incubator Building Gunnels Wood Road Stevenage Hertfordshire SG1 2FXGB
Information about Fees